These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36712177)

  • 1. Ideal Features of Topical Antibiotic Therapy for the Treatment of Impetigo: An Italian Expert Consensus Report.
    Neri I; Miraglia Del Giudice M; Novelli A; Ruggiero G; Pappagallo G; Galli L
    Curr Ther Res Clin Exp; 2023; 98():100690. PubMed ID: 36712177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Impetigo in the Pediatric Population: Consensus and Future Directions.
    Schachner LA; Torrelo A; Grada A; Micali G; Kwong PC; Scott GB; Benjamin L; Gonzalez ME; Andriessen A; Eberlein T; Eichenfield LF
    J Drugs Dermatol; 2020 Mar; 19(3):281-290. PubMed ID: 32550690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do Antimicrobial Resistance Patterns Matter? An Algorithm for the Treatment of Patients With Impetigo.
    Schachner LA; Andriessen A; Benjamin LT; Claro C; Eichenfield LF; Esposito SM; Keller L; Kircik L; Kwong PC; McCuaig C
    J Drugs Dermatol; 2021 Feb; 20(2):134-142. PubMed ID: 33538559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Impetigo and Antimicrobial Resistance.
    Schachner LA; Lynde CW; Kircik LH; Torrelo A; Hohl D; Kwong P; Oza V; Andriessen A; Hebert AA
    J Drugs Dermatol; 2021 Apr; 20(4):366-372. PubMed ID: 33852242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric impetigo: an expert panel opinion about its main controversies.
    Galli L; Novelli A; Ruggiero G; Stefani S; Fortina AB
    J Chemother; 2022 Sep; 34(5):279-285. PubMed ID: 34405763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions for impetigo.
    Koning S; van der Sande R; Verhagen AP; van Suijlekom-Smit LW; Morris AD; Butler CC; Berger M; van der Wouden JC
    Cochrane Database Syst Rev; 2012 Jan; 1(1):CD003261. PubMed ID: 22258953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic stewardship in skin infections: a cross-sectional analysis of early-career GP's management of impetigo.
    Heal C; Gorges H; van Driel ML; Tapley A; Davis J; Davey A; Holliday L; Ball J; Najib N; Spike N; FitzGerald K; Magin P
    BMJ Open; 2019 Oct; 9(10):e031527. PubMed ID: 31662391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical Ozenoxacin Cream 1% for Impetigo: A Review.
    Schachner L; Andriessen A; Bhatia N; Grada A; Patele D
    J Drugs Dermatol; 2019 Jul; 18(7):655-661. PubMed ID: 31334625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International comparison of guidelines for management of impetigo: a systematic review.
    Hall LM; Gorges HJ; van Driel M; Magin P; Francis N; Heal CF
    Fam Pract; 2022 Jan; 39(1):150-158. PubMed ID: 34184743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intolerable Burden of Impetigo in Endemic Settings: A Review of the Current State of Play and Future Directions for Alternative Treatments.
    Abrha S; Tesfaye W; Thomas J
    Antibiotics (Basel); 2020 Dec; 9(12):. PubMed ID: 33333955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impetigo incidence and treatment: a retrospective study of Dutch routine primary care data.
    Loadsman MEN; Verheij TJM; van der Velden AW
    Fam Pract; 2019 Jul; 36(4):410-416. PubMed ID: 30346521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventions for impetigo.
    Koning S; Verhagen AP; van Suijlekom-Smit LW; Morris A; Butler CC; van der Wouden JC
    Cochrane Database Syst Rev; 2004; (2):CD003261. PubMed ID: 15106198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formaldehyde as an alternative to antibiotics for treatment of refractory impetigo and other infectious skin diseases.
    Nikolic P; Mudgil P; Whitehall J
    Expert Rev Anti Infect Ther; 2019 Sep; 17(9):681-687. PubMed ID: 31393185
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of mucoactive agents in cystic fibrosis: A consensus survey of Italian specialists.
    Volpi S; Carnovale V; Colombo C; Raia V; Blasi F; Pappagallo G;
    Health Sci Rep; 2022 Jul; 5(4):e604. PubMed ID: 35677472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impetigo: A need for new therapies in a world of increasing antimicrobial resistance.
    D'Cunha NM; Peterson GM; Baby KE; Thomas J
    J Clin Pharm Ther; 2018 Feb; 43(1):150-153. PubMed ID: 29063621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial diseases of the skin.
    Edlich RF; Winters KL; Britt LD; Long WB
    J Long Term Eff Med Implants; 2005; 15(5):499-510. PubMed ID: 16218899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Impetigo with Antiseptics-Replacing Antibiotics (TIARA) trial: a single blind randomised controlled trial in school health clinics within socioeconomically disadvantaged communities in New Zealand.
    Primhak S; Gataua A; Purvis D; Thompson JMD; Walker C; Best E; Leversha A
    Trials; 2022 Feb; 23(1):108. PubMed ID: 35109906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical antibiotics in the dermatological clinical practice: Indications, efficacy, and adverse effects.
    Bonamonte D; De Marco A; Giuffrida R; Conforti C; Barlusconi C; Foti C; Romita P
    Dermatol Ther; 2020 Nov; 33(6):e13824. PubMed ID: 32531105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative review of current topical antibiotics for impetigo.
    Galindo E; Hebert AA
    Expert Opin Drug Saf; 2021 Jun; 20(6):677-683. PubMed ID: 33726585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review and meta-analysis of treatments for impetigo.
    George A; Rubin G
    Br J Gen Pract; 2003 Jun; 53(491):480-7. PubMed ID: 12939895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.